Skip Navigation

Eligible for a Gabapentin lawsuit?

Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss

Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss

A Washington woman has filed a lawsuit claiming she developed lasting neurological complications after taking gabapentin to treat fibromyalgia, raising concerns about the potential cognitive effects of a medication widely prescribed for nerve pain and other conditions.

The complaint (PDF) was brought by Anne Catherine McBride in the U.S. District Court for the Eastern District of Washington on November 9, naming Pfizer Inc. as the defendant.

McBride claims the persistent symptoms of gabapentin use have prevented her from maintaining regular employment and substantially diminished her quality of life.

Gabapentin Side Effects

The FDA first approved gabapentin in 1993 under the brand name Neurontin for the treatment of certain seizure disorders. The medication is also available under other brand names like Gralise and Horizant.

In recent years, gabapentin has been commonly prescribed for conditions beyond its FDA-approved indications, including diabetic neuropathy, fibromyalgia, chronic pain, sciatica, anxiety and alcohol use disorder. 

As gabapentin prescriptions have increased, researchers have raised concerns about the medications’ potential side effects, risk of misuse and dependence. According to the U.S. Centers for Disease Control and Prevention (CDC), gabapentin use rose by more than 200% over a 15-year period, reflecting a substantial increase in the drug’s use nationwide.

Concerns about potential long-term neurological effects have also emerged. A study published last year in the journal Regional Anesthesia and Pain Medications warned that researchers saw an increased risk of dementia among non-elderly adults taking gabapentin to combat chronic lower back pain. They urged doctors to begin monitoring the cognitive function of patients prescribed the drug.

The findings have sparked a series of gabapentin dementia lawsuits to be filed, each raising similar allegations that Pfizer, Viatris and other manufacturers failed to sufficiently examine the medication’s long-term effects on brain health or provide adequate warnings about potential memory loss and cognitive impairment.

Gabapentin Lawsuits
Gabapentin Lawsuits

Gabapentin Memory-Loss Allegations

According to the complaint, McBride was diagnosed with fibromyalgia in September 2020, following approximately five years of unexplained right hip pain. She began taking gabapentin around January 2023.

McBride alleges she developed debilitating headaches after beginning gabapentin, which continued to worsen even after she stopped taking the medication.

The complaint also alleges McBride developed memory problems that interfered with everyday activities, including forgetting where she was driving, missing turns and struggling to recall information.

Although McBride discontinued gabapentin in March 2023, she maintains the neurological symptoms persisted, with headaches becoming increasingly severe and memory problems continuing for several years.

Medical records from August 2026 that are included in the court filing also document treatment for migraines and memory concerns, including a diagnosis of migraine without aura and discussions about medication adjustments and further evaluation.

McBride claims the persistent symptoms have prevented her from maintaining regular employment, impairing her concentration, decision-making and ability to complete everyday tasks.

“Because it affects the central nervous system, gabapentin can frequently cause drowsiness, dizziness, and mild cognitive side effects like temporary forgetfulness or a ‘foggy’ feeling. It was not temporary, I felt like someone was using me as a puppet.”

— Anne Catherine McBride v. Pfizer Inc.

The lawsuit alleges gabapentin caused symptoms that substantially interfered with McBride’s daily activities and ability to maintain employment. It seeks more than $75,000 in damages, including compensation for lost earning capacity, medical expenses, pain and suffering and diminished quality of life, as well as punitive damages.

Gabapentin Lawsuits

Attorneys are currently reviewing potential gabapentin memory-loss lawsuits involving individuals who experienced serious neurological problems following long-term use of the medication. Conditions under investigation include:

  • Dementia
  • Early-onset dementia
  • Alzheimer’s disease
  • Mild cognitive impairment (MCI)

As additional claims emerge, the litigation may focus on whether drugmakers were aware of potential links between gabapentin and cognitive decline, how long those safety concerns were known and whether patients and doctors should have received stronger warnings.

Individuals who developed dementia, Alzheimer’s disease or mild cognitive impairment after extended gabapentin treatment may qualify to pursue compensation for medical expenses, lost income and other damages. Gabapentin dementia lawyers are investigating potential cases, with free consultations available to evaluate individual claims and determine whether legal action may be appropriate.

Sign up for more legal news that could affect you or your family.

Michael Adams
Written By: Michael Adams

Senior Editor & Journalist

Michael Adams is a senior editor and legal journalist at AboutLawsuits.com with over 20 years of experience covering financial, legal, and consumer protection issues. He previously held editorial leadership roles at Forbes Advisor and contributes original reporting on class actions, cybersecurity litigation, and emerging lawsuits impacting consumers.



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

About 100 different plaintiffs have filed a lawsuit alleging Amazon served as the storefront for multiple illicit nitrous oxide dealers, leading to severe injuries and addiction.

About the writer

Michael Adams

Michael Adams

Michael Adams is a senior editor and legal journalist at AboutLawsuits.com with over 20 years of experience covering financial, legal, and consumer protection issues. He previously held editorial leadership roles at Forbes Advisor and contributes original reporting on class actions, cybersecurity litigation, and emerging lawsuits impacting consumers.